Clinical Trial Update: Adjuvant FEC Versus EP in Breast Cancer (MIG5) [Phase 3]

View source ↗

Summary

A Phase 3 trial (MIG5) comparing adjuvant FEC versus EP regimens in breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• CISPLATIN (cisplatin)
• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Epirubicin (epirubicin)
• Etoposide (Etoposide)

Snippet

Sponsor: IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy | Conditions: Breast Cancer, Chemotherapy, Adjuvant | Phase 3 | Status: COMPLETED